<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03867006</url>
  </required_header>
  <id_info>
    <org_study_id>18CH036</org_study_id>
    <secondary_id>2018-A00712-53</secondary_id>
    <nct_id>NCT03867006</nct_id>
  </id_info>
  <brief_title>Optimization of the Preservation of Muscle Mass and / or Its Recovery by a Protein-energy Chrononutrition Approach Dissociated From Meals</brief_title>
  <acronym>CARBOPTIMUS</acronym>
  <official_title>Optimization of the Preservation of Muscle Mass and / or Its Recovery by a Protein-energy Chrononutrition Approach Dissociated From Meals</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire de Saint Etienne</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Bioparhom, France</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Regional Council of Auvergne-Rhône-Alpes</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Centre Hospitalier Universitaire de Saint Etienne</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Muscle wasting has a multifactorial origin, including decreased physical activity,
      malnutrition, loss of post-incident muscle recovery abilities, and decreased ability to
      regenerate muscle. Among the strategies tested to improve the production of proteins and thus
      muscle is the supplementation of whey proteins. However this strategy does not seem
      sufficient and optimal to avoid muscle wasting and it must be complemented by a complementary
      action.

      Muscle protein degradation also occurs during the nocturnal fasting periods to provide amino
      acids for energy purposes and to produce glucose, essential for vital organs. The
      preservation of the benefit of whey intake during meals could therefore be optimized by
      reducing the use of muscle proteins for energy purposes during the night.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In this study, three arms will be studied for 3 months: 1 control group, 1 group with whey
      supplementation at lunch, and 1 group with whey supplementation at lunch and an energy bolus
      before bedtime. Actions include weight and body composition monitoring, nutritional status
      and muscle function, as well as mechanistic.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 8, 2019</start_date>
  <completion_date type="Anticipated">May 2023</completion_date>
  <primary_completion_date type="Anticipated">February 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Appendicular lean body mass (gramme)</measure>
    <time_frame>Days 0 and 90</time_frame>
    <description>Comparison appendicular lean body mass between the day of inclusion and 90 days after. It is measuring by Dual Energy X-ray Absorptiometry (DEXA).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>total body composition</measure>
    <time_frame>Days 0, 45 and 90</time_frame>
    <description>Correlation between Dual Energy X-ray Absorptiometry (DEXA) results and bioelectrical impedance analysis results to determine total body composition.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Plasma albumin level (g/l)</measure>
    <time_frame>Days 0, 45 and 90</time_frame>
    <description>blood sample.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Frailty screening tool</measure>
    <time_frame>Days 0 and 90</time_frame>
    <description>Determination of fragility status. 3 status : Dependent, Fragile, Robust</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mini Nutritional Assessment score</measure>
    <time_frame>Days 0 and 90</time_frame>
    <description>Determine nutritional status. Score : 0-30</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Inflammatory status</measure>
    <time_frame>Days 0, 45 and 90</time_frame>
    <description>Analysis of inflammatory status by blood sample results. C-reactive protein (CRP), Interleukin 6 (IL-6), Tumor necrosis factor (TNFα), monocyte chemoattractant protein 1 (MCP1)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hand Grip test (N)</measure>
    <time_frame>Days 0 and 90</time_frame>
    <description>Analysis of muscle function tests.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>6 minutes walk test (m)</measure>
    <time_frame>Days 0 and 90</time_frame>
    <description>Analysis of muscle function tests.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Maximal voluntary contraction of quadriceps (N)</measure>
    <time_frame>Days 0 and 90</time_frame>
    <description>Analysis of muscle function tests.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Get up-and-go test (s)</measure>
    <time_frame>Days 0 and 90</time_frame>
    <description>Analysis of muscle function tests.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Profiles of the differential expression of potentials biomarkers</measure>
    <time_frame>Days 0, 45 and 90</time_frame>
    <description>Analysis of profiles of the differential expression of potentials biomarkers by results of blood sample with heparin, urine sample and white blood cells.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>microbiota</measure>
    <time_frame>Days 0 and 90</time_frame>
    <description>Analysis of microbiota by stool sample results.</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">93</enrollment>
  <condition>Undernutrition</condition>
  <arm_group>
    <arm_group_label>control group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Patients will be randomized in the control group. They will have test MNA (Mini Nutritional Assessment), frailty screening tool (questionnaire FiND), clinical examination, blood sample, blood sample with heparin, white blood cells, urine sample, stool sample, maximal voluntary contraction of quadriceps, walking test, get up-and-go test, Hand Grip test, physical activity questionnaire, bioelectrical impedance analysis and Dual Energy X-ray Absorptiometry (DEXA).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>protein group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients will be randomized in the protein group. They will have test MNA (Mini Nutritional Assessment), frailty screening tool (questionnaire FiND), clinical examination, blood sample, blood sample with heparin, white blood cells, urine sample, stool sample, maximal voluntary contraction of quadriceps, walking test, get up-and-go test, Hand Grip test, physical activity questionnaire, bioelectrical impedance analysis, Dual Energy X-ray Absorptiometry (DEXA) and protein.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>protein and carbohydrates group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients will be randomized in the protein and carbohydrates group. They will have test MNA (Mini Nutritional Assessment), frailty screening tool (questionnaire FiND), clinical examination, blood sample, blood sample with heparin, white blood cells, urine sample, stool sample, maximal voluntary contraction of quadriceps, walking test, get up-and-go test, Hand Grip test, physical activity questionnaire, bioelectrical impedance analysis, Dual Energy X-ray Absorptiometry (DEXA) and protein and carbohydrates.</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Protein</intervention_name>
    <description>In addition to their normal meal, patients will eat 30g of whey protein every lunch during 90 days.</description>
    <arm_group_label>protein group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Protein and Carbohydrate</intervention_name>
    <description>In addition to their normal meal, patients will eat 30g of whey protein every lunch during 90 days and eat 60g of carbohydrates 2h after every diner during 90 days.</description>
    <arm_group_label>protein and carbohydrates group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Resident on the Accommodation Establishments for Dependent Elderly Persons on the
             Mutuality of Loire, France

          -  Risk of undernutrition or moderate undernutrition with one of the following criteria :

               -  Either 5-10% of weight loss in 1 month or 10-15% in 6 months.

               -  Or Body Mass Index (BMI) between 16 and 21

               -  Or Albumin levels between 30 and 35 g/L

               -  Or global Mini Nutritional Assessment (MNA) test between 17 and 23.5

               -  Or Short Emergency Geriatric Assessment (SEGA) Score &gt;8

        Exclusion Criteria:

          -  Sub-acute pathology (flu, gastroenteritis, bacterial infections ...) or trauma
             (fracture, surgery ...) in the 30 days prior to inclusion.

          -  Hepatocellular insufficiency

          -  Heart failure with decompensation

          -  Severe dementia,

          -  Insulin-treated diabetes

          -  Renal insufficiency (clearance &lt;30 ml / min)

          -  Long-term cortico-therapy

          -  Cancer undergoing chemotherapy treatment or/and radiotherapy

          -  Gastrointestinal pathology,

          -  Diet incompatible with the nutritional protocol (intolerance to milk or lactose,
             vegetarians, vegans, ...)

          -  Motor disability leading to the impossibility of doing muscle function tests.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>65 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sergio POLAKOF, PhD</last_name>
    <role>Study Director</role>
    <affiliation>UMR 1019, INRA, France</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Frédéric ROCHE, PhD</last_name>
    <phone>(0)477829109</phone>
    <phone_ext>+33</phone_ext>
    <email>frederic.roche@chu-st-etienne.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Arnauld GARCIN, CRA</last_name>
    <phone>(0)477120286</phone>
    <phone_ext>+33</phone_ext>
    <email>arnauld.garcin@chu-st-etienne.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>EHPAD L'Adret</name>
      <address>
        <city>Bellegarde-en-Forez</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Catherine VACHÉ, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>EHPAD Les Myosotis</name>
      <address>
        <city>L'Horme</city>
        <zip>42110</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Marie-Christine MESSANA, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>EHPAD Les Tilleuls</name>
      <address>
        <city>La Grand-Croix</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Marie-Christine MESSANA, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>EHPAD Le Val Dorlay</name>
      <address>
        <city>Saint-Paul-en-Jarez</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Marie-Christine MESSANA, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Chu Saint-Etienne</name>
      <address>
        <city>Saint-Étienne</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Frédéric ROCHE, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jean-Claude BARTHELEMY, MD PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>EHPAD Bellevue</name>
      <address>
        <city>Saint-Étienne</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Fabienne PARSSEGNY, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>EHPAD Bernadette</name>
      <address>
        <city>Saint-Étienne</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Fabienne PARSSEGNY,, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>EHPAD Cité des Aînés</name>
      <address>
        <city>Saint-Étienne</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Philippe TERRAT, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>EHPAD La Cerisaie</name>
      <address>
        <city>Saint-Étienne</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Philippe TERRAT, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>EHPAD Le Soleil</name>
      <address>
        <city>Saint-Étienne</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Sophie DUHAMEL, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>EHPAD Valbenoite</name>
      <address>
        <city>Saint-Étienne</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Maria BOUQUET, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>October 22, 2018</study_first_submitted>
  <study_first_submitted_qc>March 6, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">March 7, 2019</study_first_posted>
  <last_update_submitted>June 25, 2020</last_update_submitted>
  <last_update_submitted_qc>June 25, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 26, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Malnutrition</keyword>
  <keyword>Undernutrition</keyword>
  <keyword>Elderly</keyword>
  <keyword>Protein</keyword>
  <keyword>Carbohydrate</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Malnutrition</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

